Details for New Drug Application (NDA): 084732
✉ Email this page to a colleague
NDA 084732 describes ALPHACAINE HYDROCHLORIDE W/ EPINEPHRINE, which is a drug marketed by Carlisle and is included in two NDAs. Additional details are available on the ALPHACAINE HYDROCHLORIDE W/ EPINEPHRINE profile page.
The generic ingredient in ALPHACAINE HYDROCHLORIDE W/ EPINEPHRINE is epinephrine; lidocaine hydrochloride. There are twenty-one drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.
The generic ingredient in ALPHACAINE HYDROCHLORIDE W/ EPINEPHRINE is epinephrine; lidocaine hydrochloride. There are twenty-one drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.
Summary for 084732
| Tradename: | ALPHACAINE HYDROCHLORIDE W/ EPINEPHRINE |
| Applicant: | Carlisle |
| Ingredient: | epinephrine; lidocaine hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 0.02MG/ML;2% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
